Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$0.4 - $0.91 $5,562 - $12,655
-13,907 Reduced 60.14%
9,219 $5,000
Q4 2023

Feb 06, 2024

SELL
$0.71 - $0.97 $1,948 - $2,661
-2,744 Reduced 10.61%
23,126 $21,000
Q2 2023

Aug 11, 2023

SELL
$1.59 - $2.29 $8,190 - $11,795
-5,151 Reduced 16.6%
25,870 $45,000
Q1 2023

May 02, 2023

SELL
$2.05 - $2.87 $12,150 - $17,010
-5,927 Reduced 16.04%
31,021 $71,000
Q3 2022

Nov 09, 2022

BUY
$2.6 - $5.12 $33,498 - $65,966
12,884 Added 53.54%
36,948 $106,000
Q2 2022

Aug 15, 2022

BUY
$2.19 - $3.98 $52,700 - $95,774
24,064 New
24,064 $60,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.